Lifeway Foods Acknowledges ISS Recommendation to Reject Dissident Campaign
In its report, ISS concluded that 'the dissident has not presented a compelling case for change' and advised shareholders to 'DO NOT VOTE' on all proposals put forth by Ludmila and Edward Smolyansky and their aligned group.
'We appreciate ISS's thorough review and are pleased that their recommendation supports our belief that this consent solicitation is unwarranted, disruptive and not in the best interest of Lifeway shareholders,' said Julie Smolyansky, CEO and Chair of Lifeway Foods.
The ISS analysis noted that:
Lifeway's 'financial performance has been directionally positive' and its 'share price [has] rallied over the preceding year on multiple positive earnings announcements,' with total shareholder return significantly outperforming peers in the Russell 3000 Food Producers Index.
The dissident group's critiques 'are generally presented without adequate context,' and the dissident group 'does not clearly establish how various developments have actually impacted shareholder returns.'
The dissident group 'has not presented a plan should it successfully secure a majority of board seats' for governance or operational improvement.
The dissident nominees include individuals who previously contributed to governance concerns during their past tenures at the Company.
'The Lifeway Board and management team remain focused on maximizing shareholder value and will continue to pursue all opportunities to drive additional value,' added Smolyansky. 'We encourage shareholders to follow ISS's guidance and take no action on the consent solicitation.'
About Lifeway Foods, Inc.
Lifeway Foods, Inc., which has been recognized as one of Forbes' Best Small Companies, is America's leading supplier of the probiotic, fermented beverage known as Kefir. In addition to its line of drinkable Kefir, the company also produces a variety of cheeses and a ProBugs line for kids. Lifeway's tart and tangy fermented dairy products are now sold across the United States, Mexico, Ireland, South Africa, United Arab Emirates and France. Learn how Lifeway is good for more than just you at lifewayfoods.com.
Important Additional Information
The Company intends to file a proxy statement on Schedule 14A, an accompanying BLUE proxy card and other relevant documents with the U.S. Securities and Exchange Commission (the 'SEC') in connection with the solicitation of proxies from the Company's shareholders for the Company's 2025 annual meeting of shareholders. THE COMPANY'S SHAREHOLDERS ARE STRONGLY ENCOURAGED TO READ THE COMPANY'S DEFINITIVE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO), THE ACCOMPANYING BLUE PROXY CARD AND ALL OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and shareholders may obtain a copy of the definitive proxy statement, an accompanying BLUE proxy card, any amendments or supplements to the definitive proxy statement and other documents filed by the Company with the SEC at no charge at the SEC's website at www.sec.gov. Copies will also be available at no charge by visiting the 'Investor Relations' tab of the Company's website at http://lifewaykefir.com/investor-relations/. The Company may file a consent revocation statement, in which case all references to a proxy statement, proxies, proxy cards and solicitation of proxies referenced in this 'Important Additional Information' section and the 'Participants in the Solicitation' section below shall be deemed to refer to such consent revocation statement, consent revocations, revocation cards and solicitation of consent revocations.
Participants in the Solicitation
The Company, each of its independent directors (Juan Carlos Dalto, Jody Levy, Dorri McWhorter, Perfecto Sanchez, Jason Scher and Pol Sikar) and certain of its executive officers (Julie Smolyansky, Chief Executive Officer, President and Secretary, and Eric Hanson, Chief Financial and Accounting Officer and Treasurer) are deemed to be 'participants' (as defined in Schedule 14A under the Securities Exchange Act of 1934, as amended) in the solicitation of proxies from the Company's shareholders in connection with matters to be considered at the Company's 2025 annual meeting of shareholders. Information about the names of the Company's directors and officers, their respective interests in the Company by security holdings or otherwise and their respective compensation is set forth in the 'Information About Our Directors and Executive Officers' section in Part III, Item 10 – Directors, Executive Officers and Corporate Governance of Amendment No. 1 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on April 29, 2025 (the 'Form 10-K Amendment'), in Part III, Item 11 – Executive Compensation of the Form 10-K Amendment and in the 'Security Ownership of Certain Beneficial Owners and Management' section in Part III, Item 12 – Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters of the Form 10-K Amendment. Supplemental information regarding the participants' holdings of the Company's securities can be found in SEC filings on Statements of Change in Ownership on Form 4 filed with the SEC on June 18, 2025 for Julie Smolyansky (available here) and Eric Hanson (available here) and on July 1, 2025 for each of Pol Sikar (available here), Juan Carlos Dalto (available here), Jason Scott Scher (available here), Dorri McWhorter (available here), Perfecto Sanchez (available here), and Jody Levy (available here).
Contact:
Perceptual AdvisorsDan TarmanEmail: dtarman@perceptualadvisors.com
Derek Miller Vice President of Communications, Lifeway FoodsEmail: derekm@lifeway.net
General inquiries:Lifeway Foods, Inc.Phone: 847-967-1010Email: info@lifeway.net
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Straits Times
14 hours ago
- New Straits Times
Most Asian share indexes edge up, dollar struggles for direction
SYDNEY: Most share indexes edged up in Asia on Wednesday as investors looked through weak US data and corporate warnings about the hit from tariffs, while the dollar struggled to gain ground amid growing Federal Reserve rate cut expectations. European stocks are bracing for a higher open, with EUROSTOXX 50 futures up 0.5 per cent. Wegovy-maker Novo Nordisk reported second-quarter sales growth of 18 per cent, below initial analyst expectations. Wall Street futures recovered from an earlier dip, with Nasdaq futures up 0.3 per cent and S&P 500 futures rising 0.4 per cent. Shares of AI chip stock Advanced Micro Devices slid 6.6 per cent after the bell on disappointing data centre revenue. "We see risk assets in a tug-of-war between solid US corporate earnings, powered by the artificial intelligence (AI) theme, and tariffs hurting growth while lifting inflation," said analysts at BlackRock Investment Institute. "We stay overweight US stocks but get granular while assessing the tariff fallout." Overnight, US stocks finished lower after the services sector activity unexpectedly flatlined in July. Employment further weakened and input costs climbed by the most in nearly three years, underscoring the impact from President Donald Trump's tariff policy. While US earnings have been generally upbeat in the second quarter, they are starting to show the impact of tariffs. Taco Bell parent Yum Brands missed expectations as steep trade duties dented consumer spending, while Caterpillar warned that US tariffs would cost it up to US$1.5 billion this year. In Asia, MSCI's broadest index of Asia-Pacific shares outside Japan slipped 0.1 per cent, while Japan's Nikkei gained 0.6 per cent. Australia's resource-heavy shares rose 0.8 per cent. Both Chinese blue chips and Hong Kong's Hang Seng index were up 0.1 per cent. Trump on Tuesday said it would announce tariffs on semiconductors and chips in the next week or so, while the US would initially impose a "small tariff" on pharmaceutical imports before increasing it substantially in a year or two. He also said the US was close to a trade deal with China and that he would meet his Chinese counterpart Xi Jinping before the end of the year if an agreement was struck. However, he threatened to further raise tariffs on goods from India over its Russian oil purchases. The Reserve Bank of India kept its key interest rate steady at 5.50 per cent on Wednesday, in line with expectations, but the odds of another cut have risen after the steep US tariffs on Indian exports last week. In currency markets, the dollar consolidated after sliding from two-month highs last Friday on a weak jobs report that had markets price in a near-certain chance of a Fed interest rate cut in September. The dollar index, which measures the US currency against six counterparts, was flat at 98.73 and little changed this week after Friday's 1.4 per cent fall. Fed funds futures imply a 94 per cent chance of a rate cut next month, with at least two cuts priced in for this year, according to the CME's FedWatch. Investors are waiting for Trump's pick to fill a coming vacancy on the Fed Board of Governors. Trump said the decision will be made soon, while ruling out Treasury Secretary Scott Bessent as a contender to replace current chief Jerome Powell, whose term ends in May 2026. Treasury yields edged up after a US$58 billion auction of three-year notes went poorly, but still hovered near multi-month lows. More supply will hit the market this week with US$42 billion in 10-year notes on Wednesday and US$25 billion in 30-year bonds on Thursday. Two-year Treasury yields rose 2 basis points to 3.7323 per cent, having risen 3.5 bps overnight, while benchmark 10-year yields ticked up 3 bps to 4.2217 per cent, after holding steady overnight. In commodity markets, oil prices rose after four straight sessions of declines. US crude rose 0.6 per cent to US$65.57 per barrel, while Brent was at US$68.07 per barrel, up 0.6 per cent. Trump said on Tuesday he will decide on whether to sanction countries that purchase Russian oil after a meeting with Russian officials scheduled for Wednesday. Spot gold prices slipped 0.3 per cent to US$3,370 an ounce.
The Star
a day ago
- The Star
Wall St ends lower as investors weigh tariff impact
The Dow fell 61.90 points, or 0.14%, to 44,111.74, the S&P 500 lost 30.75 points, or 0.49%, to 6,299.19 and the Nasdaq lost 137.03 points, or 0.65%, to 20,916.55. NEW YORK: US stocks ended lower on Tuesday as investors weighed the impact of tariffs after Yum Brands and other companies cited trade duties in their results or outlooks. The US trade deficit narrowed in June on a sharp drop in consumer goods imports, and the trade gap with China shrank to its lowest in more than 21 years. In addition, a measure of activity in the US services sector hit stall-speed in July, with businesses saying new import taxes are pushing costs higher. Shares of KFC parent Yum Brands fell 5.1% after the company missed estimates for the second quarter, as steep trade duties restricted consumer spending. Caterpillar warned US tariffs would pose significant challenges in the second half of the year and cost it up to US$1.5 billion in 2025, but its shares ended up 0.1%. The comments come at the tail end of the US second-quarter earnings season, in which about 80% of reports from S&P 500 companies are beating analyst profit expectations. "If you look at results, they are trending above low-bar expectations," said Terry Sandven, chief equity strategist at US Bank Wealth Management in Minneapolis, Minnesota. "The impact of tariffs remains a work in progress. We're not seeing any meaningful impact on company profitability with tariffs. We do know, however, that they loom." The Dow Jones Industrial Average fell 61.90 points, or 0.14%, to 44,111.74, the S&P 500 lost 30.75 points, or 0.49%, to 6,299.19 and the Nasdaq Composite lost 137.03 points, or 0.65%, to 20,916.55. Trump on Tuesday said the US could impose a "small tariff" on pharmaceutical imports before increasing the rate subsequently. He also signalled an announcement on tariffs on semiconductors and chips in the "next week or so." "Today's market action reflects investors that are merely in pause mode," Sandven said, noting that the backdrop for equities remains constructive for the year. The S&P 500 and Nasdaq hit a string of record highs recently, and the S&P 500 remains up 7.1% for the year so far. In other results-related news, Marriott International cut its full-year forecast for revenue growth and profit and signaled slowing travel demand and economic uncertainties. Its stock closed up 0.2%. While the earnings period is winding down, investors look forward to more key results on Wednesday, with both Walt Disney and McDonald's due to report. Advancing issues outnumbered decliners by a 1.27-to-1 ratio on the NYSE. There were 158 new highs and 67 new lows on the NYSE. On the Nasdaq, 2,216 stocks rose and 2,365 fell as declining issues outnumbered advancers by a 1.07-to-1 ratio. Volume on US exchanges was 16.29 billion shares, compared with the roughly 18.33 billion average for the full session over the last 20 trading days. — Reuters
New Straits Times
2 days ago
- New Straits Times
Chinese firms set for record US listings, undeterred by geopolitics
SHANGHAI/HONG KONG: A record number of Chinese companies are seeking a US listing this year as onerous domestic listing rules and the prospect of better valuations convince them to brave volatile China-US relations and US calls for strict oversight of Chinese firms. In the first half of 2025, 36 mostly small and mid-sized Chinese companies went public in the US, following a record-breaking year of 64 in 2024, said law firm K&L Gates. Many of those firms went public through special purpose acquisition companies (SPACs) - listed companies set up to buy mainly startups, making the startups public without them having to go through the lengthy initial public offering process. Waiting to list on the Nasdaq are more than 40 Chinese companies, including a mobile advertising service provider and a traditional Chinese medicine maker, Chinese disclosure showed. That number, which excludes confidentially filed listing applications, will take the annual tally of Chinese firms going public in the US to a new high if all materialise this year. "I think it's a healthy year for Chinese IPOs. It will probably be a record year or near that," said David Bartz, partner at K&L Gates, who has built a "robust" pipeline of Chinese clients seeking first-time share sales in the US. Chinese firms have had a harder time going public at home since the government tightened listing rules in 2023, raising the appeal of listing via SPACs in the US, as well as that country's deeper pool of capital. Pursuing a US listing amounts to a bet that calls from US lawmakers aimed at diminishing Chinese access to the world's largest capital market can only go so far, bankers and lawyers said. One listing hopeful is racing car manufacturer Xinghui Car Technology, whose head raised a toast at a Shanghai hotel in June to celebrate a major step toward going public in the US. "The U. capital market is one of the world's biggest. It's liquid and allows easy access to funding," said Xinghui Chairman Song Wenfang upon signing a preliminary agreement to be acquired by Nasdaq-listed SPAC UY Scuti. Since Xinghui's celebrations, investors have pushed US share prices to record highs, expecting trade deals to be the beginning of the end of uncertainty wrought by months of US President Donald Trump threatening to impose steep tariffs. The China Securities Regulatory Commission, which oversees Chinese firms' offshore sales of securities, did not respond to a request for comment. SPAC SURGE Over 100 Chinese firms, including technology leaders Alibaba , and Baidu, are US-listed, boasting a combined market value of about US$1 trillion as of March, showed data from the US-China Economic and Security Review Commission. In April, tearoom chain Chagee debuted on the Nasdaq after raising US$411 million in the biggest IPO of a Chinese firm in the US this year. Of those seeking to list, a growing number are pre-profit or even pre-revenue startups, mainly in the tech sector, aiming for a quicker means of raising capital through a SPAC listing, said Karen Mu, managing director at Alliance Global Partners. That demand has contributed to the total number of firms listing in the US via SPACs almost doubling last year to 57 and climbing to 76 so far this year, showed SPACInsider data. The increased Chinese interest, however, has caught the attention of US lawmakers who called for the delisting of Chinese firms from US exchanges as recently as May citing national security concerns. In June, the US Securities and Exchange Commission (SEC) singled out China as it sought to raise disclosure requirements for listing hopefuls. A spokesperson for SEC declined to comment on the Chinese listing trend beyond saying the regulator gathers information on the number of all foreign companies listed on U.S. exchanges. Spokespersons for the New York Stock Exchange and Nasdaq declined to comment. DOMESTIC HURDLES The rush of Chinese listing hopefuls heading West is being fuelled by high regulatory thresholds for listing at home as well as criteria skewed to spur growth of sectors in line with national interests. In China, a company needs to exceed a certain size or be profitable to qualify for a main-board listing. Alternatively, to list on tech boards, firms need to align with government self-sufficiency goals or achieve set levels of productivity. "In the US, as long as you can meet objective rules set by regulators, you can go public," said Steve Markscheid, managing partner of Aerion Capital, who also serves as independent director of several US-listed Chinese companies. "Things are more subjective in China. The regulator needs to analyse whether the company is good or not. Only companies judged as good can go public." It takes nine to 12 months on average for an IPO candidate in China to secure regulatory approval, compared to six to nine months in Hong Kong and four to six months in New York, showed an analysis from Merits & Tree Law Offices. The lengthy approval process and high listing thresholds means that for startups, "listing in China becomes mission impossible," said Xinghui deal adviser Ronald Shuang of Shanghai-based investment company Balloch Holding.
